We are live on ! Find out more
EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

26 hedge funds and large institutions have $3.62M invested in eFFECTOR Therapeutics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+26
Holders Change %
–
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
–
Closed
–
Calls
$162K
Puts
–
Net Calls
+$162K
Net Calls Change
+$162K

Top Buyers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
+$292K
2
ECP
Empyrean Capital Partners
California
+$270K
3
PAMP
Polar Asset Management Partners
Ontario, Canada
+$161K
4
MI
MMCAP International
Cayman Islands
+$146K
5
PC
Periscope Capital
Ontario, Canada
+$136K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$1.24M +$124K +128,247 New
AFM
2
Anson Funds Management
Texas
$1.07M +$106K +109,430 New
LA
3
Linden Advisors
New York
$179K +$292K +303,062 New
ECP
4
Empyrean Capital Partners
California
$170K +$270K +279,502 New
PAMP
5
Polar Asset Management Partners
Ontario, Canada
$102K +$161K +166,666 New
MI
6
MMCAP International
Cayman Islands
$92K +$146K +150,867 New
PC
7
Periscope Capital
Ontario, Canada
$86K +$136K +141,400 New
MIM
8
Monashee Investment Management
Massachusetts
$81K +$129K +133,332 New
FTCM
9
Fir Tree Capital Management
New York
$61K +$96.5K +99,998 New
Blackstone Inc
10
Blackstone Inc
New York
$61K +$96.5K +100,000 New
LP
11
LMR Partners
United Kingdom
$61K +$96.5K +100,000 New
SC
12
Sculptor Capital
New York
$61K +$101K +104,166 New
WP
13
Woodline Partners
California
$57K +$90.6K +93,922 New
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$54K +$85.5K +88,566 New
Citadel Advisors
15
Citadel Advisors
Florida
$48K +$77.3K +80,058 New
CH
16
CVI Holdings
Delaware
$41K +$64.3K +66,666 New
PSAMP
17
P. Schoenfeld Asset Management (PSAM)
New York
$41K +$64.3K +66,666 New
SCM
18
Saba Capital Management
New York
$21K +$33.6K +34,836 New
ACM
19
Atalaya Capital Management
New York
$20K +$31.5K +32,597 New
TCM
20
Tenor Capital Management
New York
$20K +$32.2K +33,333 New
WA
21
Whitebox Advisors
Minnesota
$20K +$32.2K +33,333 New
EAM
22
Exos Asset Management
New York
$13K +$21.2K +21,933 New
BI
23
Bulldog Investors
New Jersey
$10K +$16.1K +16,666 New
PI
24
PEAK6 Investments
Illinois
$10K +$16.1K +16,666 New
UBS Group
25
UBS Group
Switzerland
– +$69 +72 New
1
2

EFTRW Hedge Fund Activity: Q1 2021 in Review

26 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q1 2021, worth a combined $3.62M.

Buyers outnumbered sellers: 26 funds opened new EFTRW positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Linden Advisors, opening a new position worth an estimated $292K.

  • 26 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $3.62M of eFFECTOR Therapeutics, Inc. Warrant stock for Q1 2021.
  • 26 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q1 2021 and 0 closed out, a net change of +26 holders.
  • The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q1 2021 was Linden Advisors, an estimated $292K added.

Based on aggregated 13F filings for Q1 2021.